There is one more little point about Atrovent that should be noted. It does not have FDA approval for the treatment of asthma although it is used off label in emergency situations in combination with albuterol. But then I have already made reference to the EPR-3 guidelines and that probably has been already noted by some.
There is FDA approval for COPD.
This article also appeared last year. But, some COPD patients have many meds and many medical problems so it is truly difficult to single out one cause.
Risk For Cardiac Events, Cardiac Death Increased By Popular COPD Treatment
http://www.medicalnewstoday.com/articles/122842.php
Nebulized Atropine has not been used for at least 15 years due to its side effects and one of which was the drying of secretions which is not always a good thing. While atropine and Atrovent are in the same family, they have different chemical structures.
There is FDA approval for COPD.
This article also appeared last year. But, some COPD patients have many meds and many medical problems so it is truly difficult to single out one cause.
Risk For Cardiac Events, Cardiac Death Increased By Popular COPD Treatment
http://www.medicalnewstoday.com/articles/122842.php
So, let's clarify exactly why you use Atrovent, a parasympatholytic much like atropine...I haven't seen anyone mention the specific reason, so here it is. I am sure everyone is familiar with why you would use Atropine for an organophosphate poisonoing...it will dry the secretions caused by the hyper-parasympathetic state induced by the acetocholinesterase inhibition. So, to take this mechanism of action to, specifically, the asthmatic patient we need to look at what is happening.
Nebulized Atropine has not been used for at least 15 years due to its side effects and one of which was the drying of secretions which is not always a good thing. While atropine and Atrovent are in the same family, they have different chemical structures.
Last edited by a moderator: